Riskpilot← Back to searchSign inGet full accessCenter for Clinical and Basic Research A/S
A/SActiveCVR 21142743Ballerup Byvej 222Research and experimental development on natural sciences and engineering · NACE 7210Est. 19981 employees
Revenue 2024
DKK 4M
-75% vs 2023
EBITDA margin
1.9%
-98% vs 2023
Equity ratio
-9.7%
Financial strength
Net profit 2024
DKK 10,6M
-39% vs 2023
| Revenue | DKK 4M | -75% |
| EBITDA | DKK 77K | -98% |
| Net profit | DKK 10,6M | -39% |
| Total assets | DKK 92,7M | +25% |
| Equity | DKK -9M | +59% |
| Employees | 1 | — |
Legal name
Center for Clinical and Basic Research A/S
CVR number
21142743
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. september 1998
Share capital
DKK 10.000.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør i forening med et bestyrelsesmedlem eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at drive konsulentvirksomhed, investeringsvirksomhed og forskning samt hermed beslægtet virksomhed.
Address
Ballerup Byvej 222
Phone
+4544525400
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 8.573 | — | 6.240 | 7.832 | 8.205 | 6.056 | 40.638 | 120.590 | 94.361 | 88.098 | 16.071 | 3.976 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -4.307 | -0 | -2.641 | -4.595 | -5.091 | -4.986 | -17.692 | -35.398 | -25.430 | -22.070 | -600 | -214 |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.833 | — | -1.314 | 508 | 1.734 | -91 | -40.239 | 23.573 | -7.439 | 933 | 3.285 | 77 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -368 | -0 | -13 | -30 | -34 | -35 | -1.421 | -2.644 | -12.993 | -694 | -0 | -0 |
| EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.465 | — | -1.327 | 478 | 1.700 | -126 | -41.660 | 20.929 | -20.432 | 239 | 3.285 | 77 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.294 | 0 | -9.283 | 1.749 | -82.660 | -8.454 | -5.391 | -23.597 | 2.468 | 2.401 | 14.102 | 11.079 |
| Profit before tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 40.759 | — | -10.610 | 2.227 | -80.960 | -8.580 | -47.051 | -2.668 | -17.964 | 2.639 | 17.387 | 11.156 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 1.580 | -0 | -5.349 | 5.813 | -0 | 116 | 305 | -7.467 | 5.800 | -96 | -0 | 530 |
| Net profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 39.179 | — | -5.261 | -3.586 | -80.960 | -8.696 | -47.356 | 4.799 | -23.764 | 2.735 | 17.387 | 10.625 |
| Item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 585.625 | 0 | 602.914 | 367.026 | 250.410 | 265.656 | 171.534 | 152.308 | 75.316 | 77.982 | 74.084 | 92.668 |
| Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 170.756 | — | 121.929 | 117.765 | 31.838 | 24.769 | -22.342 | -18.713 | -37.633 | -35.697 | -21.663 | -8.960 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 499 | 0 | 0 | 0 | 0 | 0 | 1.296 | 2.628 | 26.866 | 0 | 0 | 32.285 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 414.370 | 0 | 480.985 | 249.261 | 218.572 | 240.887 | 192.580 | 168.393 | 86.083 | 113.679 | 95.747 | 69.343 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 414.869 | 0 | 480.985 | 249.261 | 218.572 | 240.887 | 193.876 | 171.021 | 112.949 | 113.679 | 95.747 | 101.628 |
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
19992024
Equity ratio
-9.7%
This company
38.2%
Market median
-125% vs market
19992024
Return on equity
1062543500.0%
This company
18.4%
Market median
+5774692835% vs market
19992024
Net profit margin
267.3%
This company
8.1%
Market median
+3200% vs market
19992024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
19992024
Debt / equity
11.34×
This company
0.62×
Market median
-1729% vs market
19992024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via CVR / Virk · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via CVR / Virk · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via CVR / Virk · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via CVR / Virk · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via CVR / Virk · Period 2007-01-01 – 2007-12-31
- Annual report 2006Filed via CVR / Virk · Period 2005-10-01 – 2006-12-31
- Annual report 2005Filed via CVR / Virk · Period 2004-10-01 – 2005-09-30
- Annual report 2004Filed via CVR / Virk · Period 2003-10-01 – 2004-09-30
- Annual report 2003Filed via CVR / Virk · Period 2002-10-01 – 2003-09-30
- Annual report 2002Filed via CVR / Virk · Period 2001-10-01 – 2002-09-30
- Annual report 2001Filed via CVR / Virk · Period 2000-10-01 – 2001-09-30
- Annual report 2000Filed via CVR / Virk · Period 1999-10-01 – 2000-09-30
- Annual report 1999Filed via CVR / Virk · Period 1998-09-01 – 1999-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BJ Founder | Founder | 1998 | — | — |
IV Management | Management | 2020 | — | — |
TK Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
LO Management | Management | 2003 | — | — |
RD Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
VR Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
JP Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
AC Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
DE Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
Td Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
DN Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
CH Founder | Founder | 1998 | — | — |
JJ Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
SV Chief Executive Officer | Chief Executive Officer | 1999 | — | — |
JM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
WH Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2008 | — | — | |
| Chairman | 2008 | — | — | |
| Chairman | 2001 | — | — | |
| Chairman | 1999 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2011 | — | — | |
| Chairman | 1998 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 1999 | — | — | |
| Chairman | 1999 | — | — | |
| Board of Directors | 2013 | — | — | |
| Chairman | 2006 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2008 | |
| Individual | 15.0% | 15.0% | 2016 | |
| Individual | 15.0% | 15.0% | 2016 | |
| Individual | 15.0% | 15.0% | 2016 | |
| Individual | 15.0% | 15.0% | 2016 | |
| Individual | 15.0% | 15.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Center for Clinical and Basic Research A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bente Juel Christiansen | Founder | 0 companies |
| Ivo Valter | Management | 0 companies |
| Ted Kaminer | Chief Executive Officer | 0 companies |
| Lars Olof Hedbys | Management | 0 companies |
| Roger Dale Smith | Chief Executive Officer | 0 companies |
| Victor Richard Lopes | Chief Executive Officer | 0 companies |
| Jean-Claude Provost | Chief Executive Officer | 0 companies |
| Aaron Christopher Timm | Chief Executive Officer | 0 companies |
| David Eugene Peters | Chief Executive Officer | 0 companies |
| Tertia de Jager | Chief Executive Officer | 0 companies |
| Dustin Nathan Owen | Chief Executive Officer | 0 companies |
| Claus Henrik Christiansen | Founder | 0 companies |
| Jason James Berg | Chief Executive Officer | 0 companies |
| Sten Verland | Chief Executive Officer | 0 companies |
| Jill Marie Pellegrino | Chief Executive Officer | 0 companies |
| William Hemmings Hogan | Chief Executive Officer | 0 companies |
| Thomas Nielsen | Board of Directors | 0 companies |
| Jeffrey John Bairstow | Chairman | 0 companies |
| Peter Steiger | Chairman | 0 companies |
| Michael Keldsen | Chairman | 0 companies |
| David Scott Herron | Chairman | 0 companies |
| Ralph J. Reyes | Chairman | 0 companies |
| David Carl Buhler | Board of Directors | 0 companies |
| Julia Lauren Chen | Board of Directors | 0 companies |
| Riaan van Tonder | Board of Directors | 0 companies |
| Allan Bach Sørensen | Board of Directors | 0 companies |
| David Eugene Peters | Board of Directors | 0 companies |
| Claus Juel Hansen | Board of Directors | 0 companies |
| Anders Rabing Noes | Board of Directors | 0 companies |
| Huong Thu Kraus | Board of Directors | 0 companies |
| Søren Hyllekvist | Chairman | 0 companies |
| Kurt Heeno | Chairman | 0 companies |
| Mark Di Ianni | Board of Directors | 0 companies |
| Morten Skjønnemand | Board of Directors | 0 companies |
| Jak Jacques Barbut | Chairman | 0 companies |
| Hans Christian Hoeck | Board of Directors | 0 companies |
| Gary Stephen Velasquez | Chairman | 0 companies |
| Peter Michael Krohn | Board of Directors | 0 companies |
| Henry Walter Gerock | Board of Directors | 0 companies |
| Jean-Yves Caloz | Board of Directors | 0 companies |
| Richard Stuart Harris | Board of Directors | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |
| Julia Mary James | Chairman | 0 companies |
| Christopher David Neild | Board of Directors | 0 companies |
| Kristian Martin Ramm-Larsen | Board of Directors | 0 companies |